(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502):
Strong first quarter results and confidence in Management Guidance•
Underlying revenue grew +9.1%, driven by a +15.3% increase of Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets). (Reported revenue declined -2.8% to 434. ...
Source : http://me-newswire.net//news/18412/en...